Antibody data
- Antibody Data
- Antigen structure
- References [9]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- 4377 - Provider product page
- Provider
- Cell Signaling Technology, Inc
- Proper citation
- Cell Signaling Technology Cat#4377, RRID:AB_331775
- Product name
- Phospho-p44/42 MAPK (Erk1/2) (Thr202/Tyr204) (197G2) Rabbit mAb
- Antibody type
- Monoclonal
- Reactivity
- Human, Mouse, Rat, Drosophila, Porcine, Simian, Other
- Host
- Rabbit
- Storage
- -20°C
Submitted references Differential role for CD277 as a co-regulator of the immune signal in T and NK cells.
Developmental acquisition of the Lyn-CD22-SHP-1 inhibitory pathway promotes B cell tolerance.
Acetaminophen prevents aging-associated hyperglycemia in aged rats: effect of aging-associated hyperactivation of p38-MAPK and ERK1/2.
TLR3 ligand induces NF-{kappa}B activation and various fates of multiple myeloma cells depending on IFN-{alpha} production.
Inhibition of mitogen-activated protein kinase phosphatase 3 activity by interdomain binding.
Sensitization to the lysosomal cell death pathway by oncogene-induced down-regulation of lysosome-associated membrane proteins 1 and 2.
T-cell function is partially maintained in the absence of class IA phosphoinositide 3-kinase signaling.
ShcA mediates the dominant pathway to extracellular signal-regulated kinase activation during early thymic development.
IL-27 induces Th1 differentiation via p38 MAPK/T-bet- and intercellular adhesion molecule-1/LFA-1/ERK1/2-dependent pathways.
Messal N, Mamessier E, Sylvain A, Celis-Gutierrez J, Thibult ML, Chetaille B, Firaguay G, Pastor S, Guillaume Y, Wang Q, Hirsch I, Nunès JA, Olive D
European journal of immunology 2011 Dec;41(12):3443-54
European journal of immunology 2011 Dec;41(12):3443-54
Developmental acquisition of the Lyn-CD22-SHP-1 inhibitory pathway promotes B cell tolerance.
Gross AJ, Lyandres JR, Panigrahi AK, Prak ET, DeFranco AL
Journal of immunology (Baltimore, Md. : 1950) 2009 May 1;182(9):5382-92
Journal of immunology (Baltimore, Md. : 1950) 2009 May 1;182(9):5382-92
Acetaminophen prevents aging-associated hyperglycemia in aged rats: effect of aging-associated hyperactivation of p38-MAPK and ERK1/2.
Wu M, Desai DH, Kakarla SK, Katta A, Paturi S, Gutta AK, Rice KM, Walker EM Jr, Blough ER
Diabetes/metabolism research and reviews 2009 Mar;25(3):279-86
Diabetes/metabolism research and reviews 2009 Mar;25(3):279-86
TLR3 ligand induces NF-{kappa}B activation and various fates of multiple myeloma cells depending on IFN-{alpha} production.
Chiron D, Pellat-Deceunynck C, Amiot M, Bataille R, Jego G
Journal of immunology (Baltimore, Md. : 1950) 2009 Apr 1;182(7):4471-8
Journal of immunology (Baltimore, Md. : 1950) 2009 Apr 1;182(7):4471-8
Inhibition of mitogen-activated protein kinase phosphatase 3 activity by interdomain binding.
Mark JK, Aubin RA, Smith S, Hefford MA
The Journal of biological chemistry 2008 Oct 17;283(42):28574-83
The Journal of biological chemistry 2008 Oct 17;283(42):28574-83
Sensitization to the lysosomal cell death pathway by oncogene-induced down-regulation of lysosome-associated membrane proteins 1 and 2.
Fehrenbacher N, Bastholm L, Kirkegaard-Sørensen T, Rafn B, Bøttzauw T, Nielsen C, Weber E, Shirasawa S, Kallunki T, Jäättelä M
Cancer research 2008 Aug 15;68(16):6623-33
Cancer research 2008 Aug 15;68(16):6623-33
T-cell function is partially maintained in the absence of class IA phosphoinositide 3-kinase signaling.
Deane JA, Kharas MG, Oak JS, Stiles LN, Luo J, Moore TI, Ji H, Rommel C, Cantley LC, Lane TE, Fruman DA
Blood 2007 Apr 1;109(7):2894-902
Blood 2007 Apr 1;109(7):2894-902
ShcA mediates the dominant pathway to extracellular signal-regulated kinase activation during early thymic development.
Trampont P, Zhang L, Ravichandran KS
Molecular and cellular biology 2006 Dec;26(23):9035-44
Molecular and cellular biology 2006 Dec;26(23):9035-44
IL-27 induces Th1 differentiation via p38 MAPK/T-bet- and intercellular adhesion molecule-1/LFA-1/ERK1/2-dependent pathways.
Owaki T, Asakawa M, Fukai F, Mizuguchi J, Yoshimoto T
Journal of immunology (Baltimore, Md. : 1950) 2006 Dec 1;177(11):7579-87
Journal of immunology (Baltimore, Md. : 1950) 2006 Dec 1;177(11):7579-87
No comments: Submit comment
No validations: Submit validation data